Falls in Synucleinopathies

scientific article published on 27 August 2019

Falls in Synucleinopathies is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1017/CJN.2019.287
P698PubMed publication ID31452470

P2093author name stringStephen Joza
Richard Camicioli
Fang Ba
P2860cites workImagined gait modulates neuronal network dynamics in the human pedunculopontine nucleusQ21147053
Occupational therapy for patients with Parkinson's diseaseQ24243925
Second consensus statement on the diagnosis of multiple system atrophyQ24650965
Brainstem control of locomotion and muscle tone with special reference to the role of the mesopontine tegmentum and medullary reticulospinal systemsQ26779826
Cognitive Impairment in Fall-Related Studies in Parkinson's DiseaseQ26781116
Gait and cognition: a complementary approach to understanding brain function and the risk of fallingQ26992286
Effect of rhythmic auditory stimulation on gait in Parkinsonian patients with and without freezing of gaitQ27333088
Arguing against the proposed definition changes of PDQ28079237
Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progressionQ28211928
The dopaminergic response in multiple system atrophyQ28317869
Risk of Injurious Fall and Hip Fracture up to 26 y before the Diagnosis of Parkinson Disease: Nested Case-Control Studies in a Nationwide CohortQ28601487
Diagnosis and management of dementia with Lewy bodies: third report of the DLB ConsortiumQ29614409
Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological DiseaseQ30248491
Training in mental singing while walking improves gait disturbance in Parkinson's disease patients.Q30371707
Effects of dual-task cognitive-gait intervention on memory and gait dynamics in older adults with a history of falls: a preliminary investigation.Q30375924
Fall frequency and risk assessment in early Parkinson's diseaseQ30418009
A randomised controlled trial evaluating the effect of an individual auditory cueing device on freezing and gait speed in people with Parkinson's diseaseQ30491636
Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patientsQ30688673
Highly Challenging Balance Program Reduces Fall Rate in Parkinson DiseaseQ30689523
Falls documentation in nursing homes: agreement between the minimum data set and chart abstractions of medical and nursing documentationQ30981444
Protocol for a home-based integrated physical therapy program to reduce falls and improve mobility in people with Parkinson's diseaseQ31073422
Associations between quantitative mobility measures derived from components of conventional mobility testing and Parkinsonian gait in older adultsQ31148852
Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE).Q33147006
Neurocardiovascular instability in cognitive impairment and dementia.Q33148401
Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study.Q33157400
Health and social status in patients with hip fractures and controls.Q52077699
The role of the prefrontal cortex in freezing of gait in Parkinson's disease: insights from a deep repetitive transcranial magnetic stimulation exploratory study.Q52094852
Freezing of gait: Promising avenues for future treatment.Q52351816
Cardiovascular effects of levodopa in Parkinson's disease.Q52877002
Outcomes from stimulation of the caudal zona incerta and pedunculopontine nucleus in patients with Parkinson's disease.Q53048676
Visual perception in Parkinson disease dementia and dementia with Lewy bodies.Q53266135
The prevalence, assessment and associations of falls in dementia with Lewy bodies and Alzheimer's disease.Q53333743
Task- and Context-Specific Balance Training Program Enhances Dynamic Balance and Functional Performance in Parkinsonian Nonfallers: A Randomized Controlled Trial With Six-Month Follow-Up.Q53375813
Effect of cognitive remediation on gait in sedentary seniors.Q53464045
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort studyQ56379583
Gait characteristics and falls in Parkinson's disease: A systematic review and meta-analysisQ57175702
The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodiesQ57675853
Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort studyQ58089131
Falls in people with Parkinson’s disease: A prospective comparison of community and home-based fallsQ60596736
DATATOP: A decade of neuroprotective inquiryQ61773227
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: From the advanced phase towards the late stage of the disease?Q61866746
Freezing of gait and dementia in parkinsonism: A retrospective case-control study.Q64767162
Dyskinesia and FAB score predict future falling in Parkinson's diseaseQ64778280
Clinical and anatomical predictors for freezing of gait and falls after subthalamic deep brain stimulation in Parkinson's disease patientsQ64781384
Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson DiseaseQ64785442
Age and time course of long-term motor and nonmotor complications in Parkinson diseaseQ64791301
Clinical and physiological assessments for elucidating falls risk in Parkinson's diseaseQ64813508
Progression of falls in postmortem-confirmed parkinsonian disordersQ64819962
What predicts falls in Parkinson disease?: Observations from the Parkinson's Foundation registryQ64863539
What is the therapeutic mechanism of pedunculopontine nucleus stimulation in Parkinson's disease?Q64866531
A Prospective Evaluation of an Outpatient Assessment of Postural Instability to Predict Risk of Falls in Patients with Parkinson's Disease Presenting for Deep Brain Stimulation.Q64882629
The circumstances of falls among people with Parkinson's disease and the use of Falls Diaries to facilitate reporting.Q67223294
Individual manifestations of Parkinson's disease after ten or more years of levodopaQ68843301
Falls in dementia patientsQ70647824
Fall-related injuries in dementia with Lewy bodies (DLB) and Alzheimer's diseaseQ73789704
Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's diseaseQ74404703
Effects of visual and auditory cues on gait in individuals with Parkinson's diseaseQ79838120
Effects of subthalamic nucleus stimulation and levodopa on freezing of gait in Parkinson diseaseQ81087805
Impaired attention predicts falling in Parkinson's diseaseQ81296688
Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literatureQ81568359
Risk factors for frequent falls in people with Parkinson's diseaseQ85656149
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implantsQ33159140
Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials.Q33160127
Etiology of Syncope and Unexplained Falls in Elderly Adults with Dementia: Syncope and Dementia (SYD) StudyQ33167349
Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trialsQ33199828
Incidence and prediction of falls in dementia: a prospective study in older peopleQ33444673
Objective assessment of fall risk in Parkinson's disease using a body-fixed sensor worn for 3 daysQ33573126
Cardiac Home Education and Support Trial (CHEST): a pilot studyQ33595923
Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysisQ33610208
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB ConsortiumQ33869820
The pedunculopontine nucleus: its role in the genesis of movement disordersQ33921807
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.Q34018018
Effects of a central cholinesterase inhibitor on reducing falls in Parkinson diseaseQ34135495
Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluationQ34206696
Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study groupQ34245237
Therapeutic application of repetitive transcranial magnetic stimulation: a reviewQ34311455
The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementiaQ34437544
Intravenous amantadine for freezing of gait resistant to dopaminergic therapy: a randomized, double-blind, placebo-controlled, cross-over clinical trialQ34489770
MDS clinical diagnostic criteria for Parkinson's diseaseQ34498274
Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective studyQ34502926
Ophthalmological features of Parkinson diseaseQ34548574
Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trialQ34743145
Clinical outcomes of progressive supranuclear palsy and multiple system atrophyQ34767058
Nigral stimulation for resistant axial motor impairment in Parkinson's disease? A randomized controlled trialQ34767779
Nonpharmacologic treatment of behavioral disturbance in dementiaQ34777695
Intervention strategies and risk-factor modification for falls prevention. A review of recent intervention studies.Q34785734
Prediction of falls and/or near falls in people with mild Parkinson's diseaseQ35031923
Trait impulsivity is associated with the risk of falls in Parkinson's diseaseQ35114732
Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulationQ35456828
Subthalamic stimulation modulates cortical motor network activity and synchronization in Parkinson's diseaseQ35533936
Effects of repetitive transcranial magnetic stimulation on motor symptoms in Parkinson disease: a systematic review and meta-analysisQ35562138
Pharmacotherapy of dementia with Lewy bodiesQ35574995
Falls and health status in elderly women following first eye cataract surgery: a randomised controlled trialQ35592777
Alpha oscillations in the pedunculopontine nucleus correlate with gait performance in parkinsonismQ35706455
Multiple-system atrophyQ38318175
Effects of orthostatic hypotension on cognition in Parkinson diseaseQ38383989
The mechanisms of action of deep brain stimulation and ideas for the future developmentQ38571273
Effects of deep brain stimulation on balance and gait in patients with Parkinson's disease: A systematic neurophysiological reviewQ38576396
A home program of strength training, movement strategy training and education did not prevent falls in people with Parkinson's disease: a randomised trialQ38739789
Virtual Reality for Gait Training: Can It Induce Motor Learning to Enhance Complex Walking and Reduce Fall Risk in Patients With Parkinson's Disease?Q51894948
An 8-year prospective study of the relationship between cognitive performance and falling in very old adults.Q51913615
Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.Q51925709
Rehabilitation treatment of gait in patients with Parkinson's disease with freezing: a comparison between two physical therapy protocols using visual and auditory cues with or without treadmill training.Q51936673
Dual-tasking effects on gait variability: the role of aging, falls, and executive function.Q51945707
Dementia with lewy bodies: findings from an international multicentre study.Q51971473
Dual tasking, gait rhythmicity, and Parkinson's disease: which aspects of gait are attention demanding?Q52038825
Neurotrophic factors in Parkinson's disease are regulated by exercise: Evidence-based practice.Q38783594
A novel approach to falls classification in Parkinson's disease: development of the Fall-Related Activity Classification (FRAC).Q38787870
Exercise-induced neuroprotective effects on neurodegenerative diseases: the key role of trophic factors.Q38880082
Motor dual-tasking deficits predict falls in Parkinson's disease: A prospective studyQ38892463
Use of a Short-Form Balance Confidence Scale to Predict Future Recurrent Falls in People With Parkinson DiseaseQ38969428
Effect of high-frequency subthalamic neurostimulation on gait and freezing of gait in Parkinson's disease: a systematic review and meta-analysis.Q38987173
Low FAB score as a predictor of future falling in patients with Parkinson's disease: a 2.5-year prospective studyQ38995374
Subthalamic nucleus stimulation and gait in Parkinson's Disease: a not always fruitful relationship.Q39028570
Long-term risk of falls in an incident Parkinson's disease cohort: the Norwegian ParkWest study.Q39079510
Cognitive function, gait, and gait variability in older people: a population-based studyQ39120285
Impaired executive function can predict recurrent falls in Parkinson's disease.Q39137139
Individual differences in brainstem and basal ganglia structure predict postural control and balance loss in young and older adults.Q39163021
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-upQ39216879
The relative contribution of physical and cognitive fall risk factors in people with Parkinson's disease: a large prospective cohort study.Q39313320
Intravenous amantadine on freezing of gait in Parkinson's disease: a randomized controlled trialQ39346402
Dopaminergic Therapies for Non-motor Symptoms in Parkinson's DiseaseQ39393248
Predicting first fall in newly diagnosed Parkinson's disease: Insights from a fall-naïve cohortQ39398312
The mini-BESTest can predict parkinsonian recurrent fallers: a 6-month prospective studyQ39419091
Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic HypotensionQ39438327
Paired Studies Comparing Clinical Profiles of Lewy Body Dementia with Alzheimer's and Parkinson's Diseases.Q39447026
Addition of a non-immersive virtual reality component to treadmill training to reduce fall risk in older adults (V-TIME): a randomised controlled trialQ39490774
Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trialQ39665047
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registryQ39830590
Predictors of future falls in Parkinson diseaseQ39860695
Parkinsonian single fallers versus recurrent fallers: different fall characteristics and clinical featuresQ39875586
Near-falls in people with Parkinson's disease: Circumstances, contributing factors and association with falling.Q40063109
A meta-analysis of six prospective studies of falling in Parkinson's diseaseQ40201100
Management of dementia-related behavioral disturbances: a nonpharmacologic approachQ40368924
Balance, Body Motion, and Muscle Activity After High-Volume Short-Term Dance-Based Rehabilitation in Persons With Parkinson Disease: A Pilot StudyQ40401289
Disability is an Independent Predictor of Falls and Recurrent Falls in People with Parkinson's Disease Without a History of Falls: A One-Year Prospective Study.Q40458623
Influence of urinary urgency and other urinary disturbances on falls in Parkinson's diseaseQ41004949
Operational criteria for senile dementia of Lewy body type (SDLT)Q41091449
The relationship between real world ambulatory activity and falls in incident Parkinson's disease: influence of classification schemeQ41603606
Increased risk of Parkinson's disease in cataract patients: a population-based cohort studyQ41735653
Fall frequency, predicting falls and participating in falls research: similarities among people with Parkinson's disease with and without cognitive impairment.Q41736123
Why do patients with Parkinson's disease fall? A cross-sectional analysis of possible causes of fallsQ41936290
Osteoporosis: A Hidden Nonmotor Face of Parkinson's DiseaseQ42006032
Causes of death in multiple system atrophyQ42765583
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trialQ42930136
Preventing falls in elderly peopleQ43204382
Risk factors for falls in community-dwelling patients with Alzheimer's disease and dementia with Lewy bodies: walking with visuocognitive impairment may cause a fallQ43430786
Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary studyQ43460562
Freezing of gait in PD: prospective assessment in the DATATOP cohortQ43653453
One walk a year to 1000 within a year: continuous in-home unobtrusive gait assessment of older adultsQ35753959
Tai chi and postural stability in patients with Parkinson's disease.Q35774528
Association between antidepressants and falls in Parkinson's disease.Q35826600
External validation of a simple clinical tool used to predict falls in people with Parkinson diseaseQ35875410
Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson DiseaseQ35944999
Exercise to prevent falls in older adults: an updated systematic review and meta-analysis.Q36154257
Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s diseaseQ36205357
Differential Effects of Tango Versus Dance for PD in Parkinson DiseaseQ36387726
Longitudinal falls data in Parkinson's disease: feasibility of fall diaries and effect of attritionQ36390457
Medication and subthalamic nucleus deep brain stimulation similarly improve balance and complex gait in Parkinson diseaseQ36428326
Parkinson's disease: pathophysiologyQ36495393
Levodopa Is a Double-Edged Sword for Balance and Gait in People With Parkinson's DiseaseQ36585373
Treatment of delusions in dementia with Lewy bodies - response to pharmacotherapy.Q36758947
Prevention of falls in older people with dementiaQ36844153
Efficacy of falls prevention interventions: protocol for a systematic review and network meta-analysisQ36931666
Amantadine for freezing of gait in patients with Parkinson diseaseQ36948725
Effectiveness of Non-Pharmacological Interventions to Prevent Falls in Older People: A Systematic Overview. The SENATOR Project ONTOP SeriesQ37207475
Deep brain stimulation effect on freezing of gaitQ37231152
The clinical spectrum of freezing of gait in atypical parkinsonismQ37231170
Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic HypotensionQ37265850
Diagnosis and the premotor phase of Parkinson diseaseQ37394473
Effects of single-task versus dual-task training on balance performance in older adults: a double-blind, randomized controlled trial.Q37400342
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort studyQ37401906
External validation of a 3-step falls prediction model in mild Parkinson's disease.Q37416255
Multiple component interventions for preventing falls and fall-related injuries among older people: systematic review and meta-analysisQ37591369
Recurrent falls and mortality in Parkinson's disease: a prospective two-year follow-up studyQ37764894
Risk factors for falls in community-dwelling older people: a systematic review and meta-analysisQ37768322
Effectiveness and implementation aspects of interventions for preventing falls in elderly people in long-term care facilities: a systematic review of RCTsQ37859460
The role of cognitive impairment in fall risk among older adults: a systematic review and meta-analysisQ37989101
The management of orthostatic hypotension in Parkinson's disease.Q38114882
Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson's disease: a reviewQ38156172
New targets for deep brain stimulation treatment of Parkinson's diseaseQ38161537
Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysisQ38211809
Prevention of falls in Parkinson's disease: a review of fall risk factors and the role of physical interventions.Q38237222
Differences in clinical course between dementia with Lewy bodies and Alzheimer's diseaseQ43911586
L-threo-3,4-dihydroxyphenylserine (L-DOPS) co-administered with entacapone improves freezing of gait in Parkinson's diseaseQ44363017
Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort studyQ44379328
Relationship between mild cognitive impairment and falls in older people with and without Parkinson's disease: 1-Year Prospective Cohort Study.Q44655854
Autonomic dysfunction in dementia with Lewy bodiesQ44907900
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopaQ45087241
Three simple clinical tests to accurately predict falls in people with Parkinson's disease.Q45406230
Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodiesQ46342133
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trialQ46378100
Abolishing the 1-year rule: How much evidence will be enough?Q46524557
Effects of methylphenidate on cognitive function and gait in patients with Parkinson's disease: a pilot studyQ46976250
Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohortQ47378765
Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative studyQ47612621
Falls in Parkinson's disease: A complex and evolving picture.Q47631495
Causes of Death in Chinese Patients with Multiple System AtrophyQ47639031
Motor performance differentiates individuals with Lewy body dementia, Parkinson's and Alzheimer's disease.Q47905416
Low-frequency versus high-frequency stimulation of the pedunculopontine nucleus area in Parkinson's disease: a randomised controlled trialQ48032945
A Randomized Controlled Trial to Reduce Falls in People With Parkinson's DiseaseQ48053969
The impact of low-frequency stimulation of the pedunculopontine nucleus region on reaction time in parkinsonismQ48159073
Repetitive transcranial stimulation for freezing of gait in Parkinson's diseaseQ48160786
Pallidal versus subthalamic deep-brain stimulation for Parkinson's diseaseQ48177875
Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?Q48212198
Technology-assisted balance and gait training reduces falls in patients with Parkinson's disease: a randomized controlled trial with 12-month follow-upQ48267273
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.Q48298885
Effect of Dual-Mode and Dual-Site Noninvasive Brain Stimulation on Freezing of Gait in Patients With Parkinson DiseaseQ48311027
Spinal cord stimulation improves gait in patients with Parkinson's disease previously treated with deep brain stimulationQ48424726
Unilateral pedunculopontine stimulation improves falls in Parkinson's diseaseQ48428197
rCBF changes associated with PPN stimulation in a patient with Parkinson's disease: a PET studyQ48437496
Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease.Q48452740
Impact of subthalamic nucleus stimulation on the initiation of gait in Parkinson's diseaseQ48607520
Single session intermittent theta-burst stimulation on the left premotor cortex does not alleviate freezing of gait in Parkinson's diseaseQ48692428
Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease.Q48705342
Transcranial direct current stimulation for treatment of freezing of gait: a cross-over studyQ48800103
Effects of bilateral subthalamic nucleus stimulation on parkinsonian gaitQ48813921
Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's diseaseQ48831596
Postoperative gait deterioration after bilateral subthalamic nucleus stimulation in Parkinson's diseaseQ48865419
Comparison of Self-report and Performance-Based Balance Measures for Predicting Recurrent Falls in People With Parkinson Disease: Cohort Study.Q48875510
Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trialQ48957826
Natural history of falls in an incident cohort of Parkinson's disease: early evolution, risk and protective features.Q49521363
Spinal cord stimulation therapy for gait dysfunction in advanced Parkinson's disease patientsQ50016031
Multitarget transcranial direct current stimulation for freezing of gait in Parkinson's diseaseQ50047353
Association between abnormal nocturnal blood pressure profile and dementia in Parkinson's diseaseQ50065397
Levodopa response in dementia with lewy bodies: a 1-year follow-up study.Q50268234
Are the effects of community-based dance on Parkinson disease severity, balance, and functional mobility reduced with time? A 2-year prospective pilot study.Q50635981
The incidence and risk factors of falls in Parkinson disease: prospective study.Q50682382
Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders.Q50690242
A model of free-living gait: A factor analysis in Parkinson's disease.Q51046721
Reversible improvement in severe freezing of gait from Parkinson's disease with unilateral interleaved subthalamic brain stimulation.Q51679511
Body-Fixed Sensors for Parkinson Disease.Q51788877
Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.Q51875573
P921main subjectsynucleinopathyQ2376264
P304page(s)1-14
P577publication date2019-08-27
P1433published inCanadian Journal of Neurological SciencesQ5030246
P1476titleFalls in Synucleinopathies

Search more.